Funding Details
- Awarder
- StartEngine
- Date Award
- May 01, 2022
- Vertical
- Medical Devices
- Funding URL
- View Funding Page
- Premoney Valuation
-
$1,000,000
- Valuation
-
$30,790,000
Company Info
- Founding Year
- 2018
- Traction
- The company has FDA clearance for its biopolymer and bioceramic bone implants and plans to complete animal studies required by the FDA in 2022. They have provisional patents in the U.S. and Ukraine and are expected to receive FDA clearance in late 2022 - early 2023.
- Organizations Involved
- Mount Sinai Innovation Partners, Yale Medicine, University of Connecticut
- Founders
- Denys Gurak, Ada Bovsunovsky, Markian Silecky
- Company Description
- A.D.A.M. develops an on-demand personalized implant manufacturing infrastructure with a full scope of related services, provided remotely or on site. The company focuses on creating 3D bone implants from ceramic bio-glass for flat bone implants and modified biopolymer for tubular bone implants, aiming to offer faster delivery times and biodegradable implants that stimulate osteogenesis.
- Market
- Orthopaedic Surgery, Oncology, CMF, Neuro-, and Plastic Surgery
- Location
-
Stamford,
CT,
US
- Coinvestors
- StartEngine Capital, LLC
Links